Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1992 Jul;55(7):536–541. doi: 10.1136/jnnp.55.7.536

The Scottish Motor Neuron Disease Register: a prospective study of adult onset motor neuron disease in Scotland. Methodology, demography and clinical features of incident cases in 1989.

PMCID: PMC489161  PMID: 1640227

Abstract

The Scottish Motor Neuron Disease Register (SMNDR) is a prospective, collaborative, population based study of motor neuron disease (MND) in Scotland. The register started in January 1989 with the aim of studying the clinical and epidemiological features of MND by prospectively identifying incident patients. It is based on a system of registration by recruitment from multiple sources, followed by the collection of complete clinical data and follow up, mainly through general practitioners. In this report the register's methodology and the demography and incidence data for the first year of study are presented. One hundred and fourteen newly diagnosed patients were identified in 1989 giving a crude incidence for Scotland of 2.24/100,000/year. Standardised incidence ratios showed a non-significant trend towards lower rates in north eastern regions and island areas.

Full text

PDF
536

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bharucha N. E., Schoenberg B. S., Raven R. H., Pickle L. W., Byar D. P., Mason T. J. Geographic distribution of motor neuron disease and correlation with possible etiologic factors. Neurology. 1983 Jul;33(7):911–915. doi: 10.1212/wnl.33.7.911. [DOI] [PubMed] [Google Scholar]
  2. Bobowick A. R., Brody J. A. Epidemiology of motor-neuron diseases. N Engl J Med. 1973 May 17;288(20):1047–1055. doi: 10.1056/NEJM197305172882005. [DOI] [PubMed] [Google Scholar]
  3. Buckley J., Warlow C., Smith P., Hilton-Jones D., Irvine S., Tew J. R. Motor neuron disease in England and Wales, 1959-1979. J Neurol Neurosurg Psychiatry. 1983 Mar;46(3):197–205. doi: 10.1136/jnnp.46.3.197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cendrowski W., Wender M., Owsianowski M. Analyse epidemiologique de la sclerose laterale amyotrophique sur le territoire de la grande-Pologne. Acta Neurol Scand. 1970;46(4):609–617. doi: 10.1111/j.1600-0404.1970.tb05817.x. [DOI] [PubMed] [Google Scholar]
  5. Chad D., Mitsumoto H., Adelman L. S., Bradley W. G., Munsat T. L., Zieper I. Conjugal motor neuron disease. Neurology. 1982 Mar;32(3):306–307. doi: 10.1212/wnl.32.3.306. [DOI] [PubMed] [Google Scholar]
  6. Gajdusek D. C. Urgent opportunistic observations: the study of changing, transient and disappearing phenomena of medical interest in disrupted primitive human communities. Ciba Found Symp. 1977;(49):69–94. doi: 10.1002/9780470715406.ch5. [DOI] [PubMed] [Google Scholar]
  7. Hochberg F. H., Bryan J. A., 2nd, Whelan M. A. Letter: Clustering of amyotrophic lateral sclerosis. Lancet. 1974 Jan 5;1(7845):34–34. doi: 10.1016/s0140-6736(74)93037-2. [DOI] [PubMed] [Google Scholar]
  8. Hoffman P. M., Brody J. A. The reliability of death certificate reporting for amyotrophic lateral sclerosis. J Chronic Dis. 1971 Jun;24(1):5–8. doi: 10.1016/0021-9681(71)90053-1. [DOI] [PubMed] [Google Scholar]
  9. Holloway S. M., Emery A. E. The epidemiology of motor neuron disease in Scotland. Muscle Nerve. 1982 Feb;5(2):131–133. doi: 10.1002/mus.880050209. [DOI] [PubMed] [Google Scholar]
  10. Holloway S. M., Mitchell J. D. Motor neurone disease in the Lothian Region of Scotland 1961-81. J Epidemiol Community Health. 1986 Dec;40(4):344–350. doi: 10.1136/jech.40.4.344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Juergens S. M., Kurland L. T., Okazaki H., Mulder D. W. ALS in Rochester, Minnesota, 1925-1977. Neurology. 1980 May;30(5):463–470. doi: 10.1212/wnl.30.5.463. [DOI] [PubMed] [Google Scholar]
  12. KURLAND L. T. Epidemiologic investigations of amyotrophic lateral sclerosis. III. A genetic interpretation of incidence and geographic distribution. Proc Staff Meet Mayo Clin. 1957 Aug 21;32(17):449–462. [PubMed] [Google Scholar]
  13. Kurland L. T. Amyotrophic lateral sclerosis and Parkinson's disease complex on Guam linked to an environmental neurotoxin. Trends Neurosci. 1988 Feb;11(2):51–54. doi: 10.1016/0166-2236(88)90163-4. [DOI] [PubMed] [Google Scholar]
  14. Kurland L. T. Geographic isolates: their role in neuroepidemiology. Adv Neurol. 1978;19:69–82. [PubMed] [Google Scholar]
  15. Li T. M., Alberman E., Swash M. Clinical features and associations of 560 cases of motor neuron disease. J Neurol Neurosurg Psychiatry. 1990 Dec;53(12):1043–1045. doi: 10.1136/jnnp.53.12.1043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. López-Vega J. M., Calleja J., Combarros O., Polo J. M., Berciano J. Motor neuron disease in Cantabria. Acta Neurol Scand. 1988 Jan;77(1):1–5. doi: 10.1111/j.1600-0404.1988.tb06965.x. [DOI] [PubMed] [Google Scholar]
  17. Mitchell J. D., Gibson H. N., Gatrell A. Amyotrophic lateral sclerosis in Lancashire and South Cumbria, England, 1976-1986. A geographical study. Arch Neurol. 1990 Aug;47(8):875–880. doi: 10.1001/archneur.1990.00530080057011. [DOI] [PubMed] [Google Scholar]
  18. Mulder D. W., Kurland L. T., Offord K. P., Beard C. M. Familial adult motor neuron disease: amyotrophic lateral sclerosis. Neurology. 1986 Apr;36(4):511–517. doi: 10.1212/wnl.36.4.511. [DOI] [PubMed] [Google Scholar]
  19. Munsat T. L., Skerry L., Korf B., Pober B., Schapira Y., Gascon G. G., al-Rajeh S. M., Dubowitz V., Davies K., Brzustowicz L. M. Phenotypic heterogeneity of spinal muscular atrophy mapping to chromosome 5q11.2-13.3 (SMA 5q). Neurology. 1990 Dec;40(12):1831–1836. doi: 10.1212/wnl.40.12.1831. [DOI] [PubMed] [Google Scholar]
  20. Murros K., Fogelholm R. Amyotrophic lateral sclerosis in Middle-Finland: an epidemiological study. Acta Neurol Scand. 1983 Jan;67(1):41–47. doi: 10.1111/j.1600-0404.1983.tb04543.x. [DOI] [PubMed] [Google Scholar]
  21. Olivares L., Estéban E. S., Alter M. Mexican "resistance" to amyotrophic lateral sclerosis. Arch Neurol. 1972 Nov;27(5):397–402. doi: 10.1001/archneur.1972.00490170029005. [DOI] [PubMed] [Google Scholar]
  22. Paolino E., Granieri E., Tola M. R., Rosati G. Conjugal amyotrophic lateral sclerosis. Ann Neurol. 1983 Dec;14(6):699–699. doi: 10.1002/ana.410140627. [DOI] [PubMed] [Google Scholar]
  23. Pestronk A., Cornblath D. R., Ilyas A. A., Baba H., Quarles R. H., Griffin J. W., Alderson K., Adams R. N. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol. 1988 Jul;24(1):73–78. doi: 10.1002/ana.410240113. [DOI] [PubMed] [Google Scholar]
  24. Salemi G., Fierro B., Arcara A., Cassata M., Castiglione M. G., Savettieri G. Amyotrophic lateral sclerosis in Palermo, Italy: an epidemiological study. Ital J Neurol Sci. 1989 Oct;10(5):505–509. doi: 10.1007/BF02333946. [DOI] [PubMed] [Google Scholar]
  25. Siddique T., Figlewicz D. A., Pericak-Vance M. A., Haines J. L., Rouleau G., Jeffers A. J., Sapp P., Hung W. Y., Bebout J., McKenna-Yasek D. Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity. N Engl J Med. 1991 May 16;324(20):1381–1384. doi: 10.1056/NEJM199105163242001. [DOI] [PubMed] [Google Scholar]
  26. Sienko D. G., Davis J. P., Taylor J. A., Brooks B. R. Amyotrophic lateral sclerosis. A case-control study following detection of a cluster in a small Wisconsin community. Arch Neurol. 1990 Jan;47(1):38–41. doi: 10.1001/archneur.1990.00530010046017. [DOI] [PubMed] [Google Scholar]
  27. Stanhope J. M., Brody J. A., Morris C. E. Epidemiologic features of amyotropic lateral sclerosis and parkinsonism-dementia in Guam, Mariana Islands. Int J Epidemiol. 1972 Autumn;1(3):199–210. doi: 10.1093/ije/1.3.199. [DOI] [PubMed] [Google Scholar]
  28. Steele J. C., Guzman T. Observations about amyotrophic lateral sclerosis and the parkinsonism-dementia complex of Guam with regard to epidemiology and etiology. Can J Neurol Sci. 1987 Aug;14(3 Suppl):358–362. doi: 10.1017/s0317167100037744. [DOI] [PubMed] [Google Scholar]
  29. Tandan R., Bradley W. G. Amyotrophic lateral sclerosis: Part 2. Etiopathogenesis. Ann Neurol. 1985 Oct;18(4):419–431. doi: 10.1002/ana.410180402. [DOI] [PubMed] [Google Scholar]
  30. Teräväinen H., Calne D. B. Developments in understanding the physiology and pharmacology of parkinsonism. Acta Neurol Scand. 1979 Jul;60(1):1–11. doi: 10.1111/j.1600-0404.1979.tb02946.x. [DOI] [PubMed] [Google Scholar]
  31. Williams D. B., Windebank A. J. Motor neuron disease (amyotrophic lateral sclerosis). Mayo Clin Proc. 1991 Jan;66(1):54–82. doi: 10.1016/s0025-6196(12)61175-6. [DOI] [PubMed] [Google Scholar]
  32. Yoshida S., Mulder D. W., Kurland L. T., Chu C. P., Okazaki H. Follow-up study on amyotrophic lateral sclerosis in Rochester, Minn., 1925 through 1984. Neuroepidemiology. 1986;5(2):61–70. doi: 10.1159/000110815. [DOI] [PubMed] [Google Scholar]
  33. Younger D. S., Chou S., Hays A. P., Lange D. J., Emerson R., Brin M., Thompson H., Jr, Rowland L. P. Primary lateral sclerosis. A clinical diagnosis reemerges. Arch Neurol. 1988 Dec;45(12):1304–1307. doi: 10.1001/archneur.1988.00520360022005. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES